品牌簡介

KAMIYA BIOMEDICAL COMPANY was founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California and relocated to Seattle, Washington in 1996. Our company's purpose is supplying the life science and medical communities with innovative laboratory research and diagnostic tools of the highest quality. KAMIYA is an independent American company that serves worldwide markets. Since 1983 The company's first products were protein kinase inhibitors, staurosporine and its analog, K252a. Staurosporine was discovered in 1977 by Dr. Satoshi Ohmura who is a 2015 Nobel Prize winner. This was the first commercially available staurosporine. Today, staurosporine is one of the most popular research tools in life science research fields. Today, KAMIYA's life science product lines include thousands of human and animal biomarker assays for preclinical testing with one of the largest selections of ELISA kits in the world.